- Home
- TEX vs HCM Comparison
TEX vs HCM Comparison
Compare TEX & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEX
- HCM
- Stock Information
- Founded
- TEX 1933
- HCM 2000
- Country
- TEX United States
- HCM Hong Kong
- Employees
- TEX N/A
- HCM N/A
- Industry
- TEX Construction/Ag Equipment/Trucks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- TEX Industrials
- HCM Health Care
- Exchange
- TEX Nasdaq
- HCM Nasdaq
- Market Cap
- TEX 3.0B
- HCM 2.6B
- IPO Year
- TEX N/A
- HCM N/A
- Fundamental
- Price
- TEX $37.50
- HCM $14.99
- Analyst Decision
- TEX Hold
- HCM Hold
- Analyst Count
- TEX 10
- HCM 1
- Target Price
- TEX $54.22
- HCM $19.00
- AVG Volume (30 Days)
- TEX 1.2M
- HCM 85.0K
- Earning Date
- TEX 04-24-2025
- HCM 03-19-2025
- Dividend Yield
- TEX 1.77%
- HCM N/A
- EPS Growth
- TEX N/A
- HCM N/A
- EPS
- TEX 4.96
- HCM 0.04
- Revenue
- TEX $5,127,000,000.00
- HCM $630,201,000.00
- Revenue This Year
- TEX $6.38
- HCM $28.98
- Revenue Next Year
- TEX $4.14
- HCM $20.41
- P/E Ratio
- TEX $7.76
- HCM $69.52
- Revenue Growth
- TEX N/A
- HCM N/A
- 52 Week Low
- TEX $36.15
- HCM $12.84
- 52 Week High
- TEX $68.08
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- TEX 37.25
- HCM 46.43
- Support Level
- TEX $37.98
- HCM $14.00
- Resistance Level
- TEX $41.34
- HCM $15.57
- Average True Range (ATR)
- TEX 1.40
- HCM 0.45
- MACD
- TEX 0.20
- HCM -0.12
- Stochastic Oscillator
- TEX 14.58
- HCM 29.55
About TEX Terex Corporation
Terex is a top manufacturer of aerial work platforms, materials processing equipment, and specialty equipment, such as material handlers, cranes, and concrete mixer trucks. Its current composition is a result of numerous acquisitions over several decades and a recent shift to focus on its two core segments after divesting a handful of underperforming businesses. Terex's remaining segments see heavy demand in nonresidential construction as well as in maintenance, manufacturing, energy, and materials management.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.